Chat with this insight
Save time and jump to the most important pieces.
Recent Analyst Ratings for $TLMD
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/1/2022 | $3.00 | Neutral | Credit Suisse |
2/7/2022 | $2.00 → $3.00 | Neutral | Credit Suisse |
2/4/2022 | Buy → Hold | Benchmark | |
2/3/2022 | $6.00 → $3.00 | Outperform → Sector Perform | RBC Capital |
2/3/2022 | $4.00 → $3.00 | Outperform → Neutral | Baird |
1/7/2022 | $6.00 → $2.00 | Outperform → Neutral | Credit Suisse |
8/13/2021 | $10.00 → $6.00 | Outperform | RBC Capital |
8/13/2021 | $11.00 → $8.50 | Outperform | Credit Suisse |
Securonix Appoints Eunice Kim as General Counsel
Veteran Legal Executive Brings More Than Two Decades of Experience in Private and Public Sector Regulatory Affairs, Ethics and Compliance to Unified Defense SIEM Leader Securonix, Inc., a leader in Unified Defense SIEM, today announced the appointment of Eunice Kim as general counsel. In this role, Kim will be responsible for leading Securonix's legal and compliance functions, enhancing processes for evaluating expansion and growth opportunities, and implementing corporate policies that support the company's mission, vision and values. "Eunice is a dynamic legal executive, and we are thrilled to welcome her to Securonix," said Nayaki Nayyar, Chief Executive Officer, Securonix. "Her prov
SOC Telemed Completes Acquisition by Patient Square Capital
HERNDON, Va., April 6, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on February 3, 2022, and SOC Telemed's stockholders approved the transaction at the Special Meeting of Stockholders held on April 4, 2022. Upon completion of the acquisition, SOC Telemed stockholders received $3.00 in cash per share of Class A common stock. SOC Telemed's Class A common stock and warr
SOC Telemed Stockholders Approve Acquisition by Patient Square Capital
HERNDON, Va., April 4, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced that its stockholders approved the acquisition of SOC Telemed by Patient Square Capital, a leading dedicated health care investment firm, at a special meeting. Steve Shulman, Chairman of the SOC Telemed Board of Directors, said, "On behalf of the SOC Telemed Board, I would like to thank our stockholders for their support of this transaction. Today's vote represents an important milestone towards
Credit Suisse resumed coverage on SOC Telemed with a new price target
Credit Suisse resumed coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00
Credit Suisse reiterated coverage on SOC Telemed with a new price target
Credit Suisse reiterated coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00 from $2.00 previously
SOC Telemed downgraded by Benchmark
Benchmark downgraded SOC Telemed from Buy to Hold
SEC Form 4: Warburg Pincus & Co. returned $101,624,895 worth of shares to the company (33,874,965 units at $3.00)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
SEC Form 4: Warburg Pincus & Co. returned $101,624,895 worth of shares to the company (33,874,965 units at $3.00)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
SEC Form 4: Shulman Steven J returned $3,336,873 worth of shares to the company (1,112,291 units at $3.00), closing all direct ownership in the company (tax liability)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
SEC Form 15-12B filed by SOC Telemed Inc.
15-12B - SOC Telemed, Inc. (0001791091) (Filer)
SEC Form EFFECT filed by SOC Telemed Inc.
EFFECT - SOC Telemed, Inc. (0001791091) (Filer)
SEC Form EFFECT filed by SOC Telemed Inc.
EFFECT - SOC Telemed, Inc. (0001791091) (Filer)
Anne McGeorge, Former Managing Partner of Grant Thornton LLP, Joins CitiusTech’s Board of Directors and Chair of the Audit Committee
PRINCETON, N.J.--(BUSINESS WIRE)--CitiusTech, a leading provider of healthcare technology services and solutions, announced today that Anne McGeorge, former Managing Partner of Grant Thornton’s Global Health Care and Life Sciences Practices, has joined its Board of Directors and chair of the Audit Committee. Ms. McGeorge comes with over 35 years of experience advising healthcare clients in all aspects of finance and transformational change, including strategy, M&A, joint ventures, financial statement audits, corporate restructuring, governance, talent acquisition, executive compensation, IRS matters and risk management. She created the healthcare / life sciences practice for Gran
SOC Telemed Reports Third Quarter 2021 Financial and Operating Results
RESTON, Va., Nov. 12, 2021 /PRNewswire/ -- SOC Telemed, Inc., (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced its financial and operating results for the third quarter ending September 30, 2021. SOC Telemed Reports Third Quarter 2021 Financial and Operating Results "We are proud of our third quarter results as the new organization came together with renewed focus resulting in the highest quarterly revenue and bookings in our company's history," said Dr. Chris Gallagher, Chief Executive Officer. "Upon joining the Company, my first task h
SOC Telemed to Provide Corporate and Financial Update for the Third Quarter 2021 on November 12, 2021
RESTON, Va., Oct. 29, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the company will provide a corporate and financial update for the third quarter 2021, on Friday, November 12, 2021, before market open. SOC Telemed's management team will host a conference call and live audio webcast at 8:00 a.m. ET. To participate in the call, dial either the domestic or international number or join the webcast from your computer or mobile phone. Domestic: (877) 292-0959 International: (412) 542-4143 Passco
SOC Telemed Announces Introductory Conference Call with New Leadership
RESTON, Va., Sept. 7, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the Company will host an introductory conference call with new leadership, which was announced on September 1, 2021. Dr. Chris Gallagher, CEO of the Company, and Joe Greskoviak, Vice Chairman of the Board of Directors, will host the call on Thursday, September 9, 2021, at 5 p.m. ET. Dial-In Numbers Domestic: (877) 292-0959 International: (412) 542-4143 Passcode: please ask to join the SOC Telemed call A live audio webcast w
SEC Form SC 13D/A filed by SOC Telemed Inc. (Amendment)
SC 13D/A - SOC Telemed, Inc. (0001791091) (Subject)
SEC Form SC 13G filed by SOC Telemed Inc.
SC 13G - SOC Telemed, Inc. (0001791091) (Subject)
SEC Form SC 13G/A filed by SOC Telemed Inc. (Amendment)
SC 13G/A - SOC Telemed, Inc. (0001791091) (Subject)